New aspects in the diagnosis and treatment of cushing disease

Cushing disease which is caused by the excessive production of ACTH is a rare and complex endocrine disorder that still represents a major challenge for the physician in terms of accurate diagnosis and efficient treatment. Diagnosing Cushing syndrome and its etiology is an elaborate procedure and no...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Labeur, M., Theodoropoulou, M., Sievers, C., Paez-Pereda, M., Castillo, V., Arzt, E., Stalla, G.K.
Formato: SER
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_03013073_v35_n_p169_Labeur
Aporte de:
id todo:paper_03013073_v35_n_p169_Labeur
record_format dspace
spelling todo:paper_03013073_v35_n_p169_Labeur2023-10-03T15:18:18Z New aspects in the diagnosis and treatment of cushing disease Labeur, M. Theodoropoulou, M. Sievers, C. Paez-Pereda, M. Castillo, V. Arzt, E. Stalla, G.K. dopamine receptor stimulating agent drug derivative ligand peroxisome proliferator activated receptor gamma retinoic acid somatostatin algorithm animal conference paper Cushing disease differential diagnosis human Algorithms Animals Diagnosis, Differential Dopamine Agonists Humans Ligands Pituitary ACTH Hypersecretion PPAR gamma Somatostatin Tretinoin Cushing disease which is caused by the excessive production of ACTH is a rare and complex endocrine disorder that still represents a major challenge for the physician in terms of accurate diagnosis and efficient treatment. Diagnosing Cushing syndrome and its etiology is an elaborate procedure and no single test is sensitive and specific enough to provide sufficient accuracy. Therefore, an ordered cascade of tests is necessary recommended by a consensus statement in 2002. The proposed diagnostic algorithm will be summarized in the following section. In the absence of efficient drug therapy, transsphenoidal resection of the pituitary adenoma is the treatment of choice for the reduction of ACTH secretion. However, not all patients can be cured by surgery. In the present article, we examine recent studies that have investigated the therapeutic potential of new generations of drugs for the treatment of Cushing disease such as cabergoline and SOM230. The role of nuclear receptors: retinoic acid receptors and peroxisome proliferator-activated receptor-γ as new approaches for treating pituitary tumors is also discussed. Copyright © 2006 S. Karger AG. Fil:Labeur, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Paez-Pereda, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. SER info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03013073_v35_n_p169_Labeur
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic dopamine receptor stimulating agent
drug derivative
ligand
peroxisome proliferator activated receptor gamma
retinoic acid
somatostatin
algorithm
animal
conference paper
Cushing disease
differential diagnosis
human
Algorithms
Animals
Diagnosis, Differential
Dopamine Agonists
Humans
Ligands
Pituitary ACTH Hypersecretion
PPAR gamma
Somatostatin
Tretinoin
spellingShingle dopamine receptor stimulating agent
drug derivative
ligand
peroxisome proliferator activated receptor gamma
retinoic acid
somatostatin
algorithm
animal
conference paper
Cushing disease
differential diagnosis
human
Algorithms
Animals
Diagnosis, Differential
Dopamine Agonists
Humans
Ligands
Pituitary ACTH Hypersecretion
PPAR gamma
Somatostatin
Tretinoin
Labeur, M.
Theodoropoulou, M.
Sievers, C.
Paez-Pereda, M.
Castillo, V.
Arzt, E.
Stalla, G.K.
New aspects in the diagnosis and treatment of cushing disease
topic_facet dopamine receptor stimulating agent
drug derivative
ligand
peroxisome proliferator activated receptor gamma
retinoic acid
somatostatin
algorithm
animal
conference paper
Cushing disease
differential diagnosis
human
Algorithms
Animals
Diagnosis, Differential
Dopamine Agonists
Humans
Ligands
Pituitary ACTH Hypersecretion
PPAR gamma
Somatostatin
Tretinoin
description Cushing disease which is caused by the excessive production of ACTH is a rare and complex endocrine disorder that still represents a major challenge for the physician in terms of accurate diagnosis and efficient treatment. Diagnosing Cushing syndrome and its etiology is an elaborate procedure and no single test is sensitive and specific enough to provide sufficient accuracy. Therefore, an ordered cascade of tests is necessary recommended by a consensus statement in 2002. The proposed diagnostic algorithm will be summarized in the following section. In the absence of efficient drug therapy, transsphenoidal resection of the pituitary adenoma is the treatment of choice for the reduction of ACTH secretion. However, not all patients can be cured by surgery. In the present article, we examine recent studies that have investigated the therapeutic potential of new generations of drugs for the treatment of Cushing disease such as cabergoline and SOM230. The role of nuclear receptors: retinoic acid receptors and peroxisome proliferator-activated receptor-γ as new approaches for treating pituitary tumors is also discussed. Copyright © 2006 S. Karger AG.
format SER
author Labeur, M.
Theodoropoulou, M.
Sievers, C.
Paez-Pereda, M.
Castillo, V.
Arzt, E.
Stalla, G.K.
author_facet Labeur, M.
Theodoropoulou, M.
Sievers, C.
Paez-Pereda, M.
Castillo, V.
Arzt, E.
Stalla, G.K.
author_sort Labeur, M.
title New aspects in the diagnosis and treatment of cushing disease
title_short New aspects in the diagnosis and treatment of cushing disease
title_full New aspects in the diagnosis and treatment of cushing disease
title_fullStr New aspects in the diagnosis and treatment of cushing disease
title_full_unstemmed New aspects in the diagnosis and treatment of cushing disease
title_sort new aspects in the diagnosis and treatment of cushing disease
url http://hdl.handle.net/20.500.12110/paper_03013073_v35_n_p169_Labeur
work_keys_str_mv AT labeurm newaspectsinthediagnosisandtreatmentofcushingdisease
AT theodoropouloum newaspectsinthediagnosisandtreatmentofcushingdisease
AT sieversc newaspectsinthediagnosisandtreatmentofcushingdisease
AT paezperedam newaspectsinthediagnosisandtreatmentofcushingdisease
AT castillov newaspectsinthediagnosisandtreatmentofcushingdisease
AT arzte newaspectsinthediagnosisandtreatmentofcushingdisease
AT stallagk newaspectsinthediagnosisandtreatmentofcushingdisease
_version_ 1807321100626952192